SkinHealth Systems Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $300.8M | $334.3M | $398.0M | $365.9M | $260.1M |
| Cost of revenue | $104.4M | $152.0M | $242.9M | $117.1M | $81.5M |
| Gross profit | $196.4M | $182.3M | $155.1M | $248.8M | $178.5M |
| Research and development | $5.6M | $6.3M | $10.1M | $8.4M | $8.2M |
| Operating expenses | $217.2M | $250.1M | $286.0M | $274.6M | $218.5M |
| Operating income | -$20.8M | -$67.8M | -$130.9M | -$25.8M | -$39.9M |
| Interest expense | $19.3M | $10.4M | $13.6M | $13.4M | $11.8M |
| Pretax income | -$5.9M | -$29.6M | -$101.9M | $45.3M | -$380.6M |
| Income tax expense | $3.6M | -$452,000 | -$1.8M | $1.1M | -$1.9M |
| Net income | -$9.5M | -$29.1M | -$100.1M | $44.2M | -$378.8M |
| Balance Sheet | |||||
| Cash and equivalents | — | — | $523.0M | $568.2M | $901.9M |
| Current assets | $309.5M | $477.1M | $698.3M | $783.3M | $1.0B |
| Total assets | $499.8M | $685.7M | $929.1M | $1.0B | $1.2B |
| Current liabilities | $186.3M | $68.2M | $115.0M | $71.7M | $76.4M |
| Total liabilities | $438.7M | $633.9M | $869.7M | $836.0M | $916.5M |
| Stockholders' equity | $61.1M | $51.8M | $59.4M | $167.1M | $298.0M |
| Cash Flow Statement | |||||
| Cash from operations | $37.5M | $16.1M | $21.8M | -$106.6M | -$28.4M |
| Depreciation and amortization | $3.8M | $9.9M | $11.3M | $7.2M | $4.5M |
| Stock-based compensation | $14.8M | $26.7M | $22.5M | $28.5M | $12.4M |
| Capital expenditure | $303,000 | $756,000 | $3.8M | $10.8M | $11.2M |
| Free cash flow | $37.2M | $15.4M | $17.9M | -$117.4M | -$39.6M |
| Share repurchases | $0 | $0 | $30.2M | $160.0M | $0 |
Shares outstanding 129.6M · Free float 22.9%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.